Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

Every generation reaches a point when progress demands proof. For Europe, following Singapore's unprecedented action to usher in circularity, that moment is now. It's unfolding in Valladolid, Spain, ...

Guest writer Dr Kun-Yu Wang describes how the development of a tunable MOF illustrates chemistry's potential in mechanical ...

SMX also amended its 2022 Incentive Equity Plan, boosting authorized ordinary shares from about 1.004 million to 9.11 million ...

Co-Diagnostics, Inc. (the "Company" or "Co-Dx"), a molecular diagnostics company with a patented platform for developing advanced molecular diagnostic tests, today announced that it has engaged Maxim ...

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Europe's green economy just got its first real ledger. Not the kind filled with estimates, pledges, or recycled buzzwords, but one written in chemistry, code, and truth. In Valladolid, Spain, SMX ...

Optibrium, a leading developer of software and AI solutions for molecular design, today announced the release of StarDrop 8, ...

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide.

Temperature is a key physiological factor that determines the speed of immune reactions. While this may seem obvious, it has remained largely unexplored at the single-cell level-until now.

Plus, TPG buys Hologic, UTSW researchers named to National Academy of Medicine, and Verily partners with NVIDIA.